# AstraZeneca Reports Third-Quarter Core Earnings of $2.79 Per Share By John Kim Canonical URL: https://www.tokenpost.com/news/business/44464 Published: 2026-10-30T09:17:47.000Z Updated: 2026-10-30T09:17:47.000Z Section: Business > Core earnings per share rose 19% at constant exchange rates. Oncology revenue increased 16% in the first nine months of 2026. AstraZeneca PLC reported third-quarter core earnings of $2.79 per share, up 19% at constant exchange rates. The company’s oncology revenue rose 16% during the first nine months of 2026. The oncology growth figure covers the nine-month period, while the earnings figure is for the third quarter. The results follow [TokenPost’s preview of AstraZeneca’s scheduled earnings release](). ## Links in this article - [TokenPost’s preview of AstraZeneca’s scheduled earnings release](https://www.tokenpost.com/news/business/43785)